Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mechanistic and antigenic boundaries of Henipavirus and Parahenipavirus glycoproteins.

Nature communications·2026

Same author

Impact of Fruit and Vegetable Incentive Programs on Food Insecurity, Fruit and Vegetable Consumption, and Health Outcomes: A Community Guide Systematic Review.

American journal of preventive medicine·2024

Same author

Phentermine plus topiramate for the treatment of obesity.

Expert review of endocrinology & metabolism·2019

Same author

Statistical methods used in the public health literature and implications for training of public health professionals.

PloS one·2017

Same author

A prospective analysis of the association between cardiovascular disease and depression in middle-aged women.

Menopause (New York, N.Y.)·2011

Same author

Engineered biosynthesis of nonribosomal lipopeptides with modified fatty acid side chains.

Journal of the American Chemical Society·2007

Search research articles

Related Experiment Video

Updated: Dec 22, 2025

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Obesity: Pharmacotherapy.

Amanda Powell¹

¹Lahey Medical Weight Loss, 50 Burlington Mall Road, Burlington, MA 01805.

|May 9, 2020

Summary

This summary is machine-generated.

Pharmacotherapy is an option for adults with obesity or overweight and coexisting conditions, when combined with lifestyle changes. Five drugs are approved for weight management, with individualized plans and regular benefit assessments recommended.

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Self-Administration of Drugs in Mouse Models of Feeding and Obesity

Self-Administration of Drugs in Mouse Models of Feeding and Obesity

Published on: June 8, 2021

Related Experiment Videos

Last Updated: Dec 22, 2025

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Self-Administration of Drugs in Mouse Models of Feeding and Obesity

Self-Administration of Drugs in Mouse Models of Feeding and Obesity

Published on: June 8, 2021

Area of Science:

Endocrinology
Metabolic Diseases
Pharmacology

Background:

Obesity affects millions globally, increasing the risk of serious health conditions.
Lifestyle interventions are foundational but often insufficient for significant weight loss.
Pharmacotherapy offers an adjunct to lifestyle changes for eligible individuals.

Purpose of the Study:

To review current pharmacotherapy options for adult weight management.
To outline criteria for initiating and managing weight management medications.
To emphasize the role of pharmacotherapy in conjunction with lifestyle modifications.

Main Methods:

Review of currently approved weight management medications for adults.
Discussion of patient selection criteria based on BMI and comorbidities.
Emphasis on individualized treatment plans and regular efficacy assessment.

Main Results:

Five drugs are approved for adult weight management: phentermine, orlistat, phentermine-topiramate, bupropion-naltrexone, and liraglutide.
Pharmacotherapy, combined with lifestyle interventions, leads to greater weight loss and maintenance.
Treatment should be individualized, considering patient needs, contraindications, and cost.

Conclusions:

Pharmacotherapy is a viable option for patients with obesity or overweight meeting specific criteria.
Continuous lifestyle modification is crucial alongside pharmacotherapy for optimal outcomes.
Regular monitoring and potential medication adjustment are necessary to ensure treatment effectiveness.